Rule 8 - Nestor Healthcare Group Plc
August 20 2003 - 12:42PM
UK Regulatory
Fax no 44 20 7256 9386 FORM 8.1/8.3
Lodge with a RIS or Newstrack and the Takeover Panel. Use separate form for each
class of securities in which dealings have been made.
Date of disclosure 20 Aug 2003
DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) AND 8.3
OF THE CITY CODE ON TAKEOVERS AND MERGERS
Date of dealing 13 Aug 2003
Dealing in: Nestor Healthcare Group Plc
(1) Class of securities: ordinary shares
(2) Amount bought Amount sold Price per unit
500,000 3.12 GBP
(3) Resultant total of the same class owned or controlled (and percentage of class)
638,800 0.73 percent ( 0.73 %)
(4) Party making disclosure: Robeco
(5) EITHER (a) Name of purchaser/vendor (Note 1)
OR (b) If dealing for discretionary client(s), name of fund
management organisation
Robeco (for underlying funds)
(6) Reason for disclosure (Note 2)
(a) associate of (i) offeror (Note 3) NO
(ii) offeree company NO
Specify which category or categories of associate (1-8 overleaf) .................
If category (8), explain .........................................................
..................................................................................
(b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of
the class of relevant securities dealt in) YES
Signed, for and on behalf of the party named in (4) above ..........................
(Also print name of signatory) JF Goedhart
Telephone and extension number ++ 31 10 224 3390
______________________________________
Note 1. Specify owner, not nominee or vehicle company. If relevant, also
identify controller of owner, eg where an owner normally acts on
instructions of a controller.
Note 2. Disclosure might be made for more than one reason; if so, state all
reasons.
Note 3. Specify which offeror if there is more than one.
Note 4. When an arrangement exists with any offeror, with the offeree company
or with an associate of any offeror or of the offeree company in
relation to relevant securities, details of such arrangement must be
disclosed, as required by Note 6 on Rule 8.
Note 5. It may be necessary, particularly when disclosing derivative transactions,
to append a sheet to this disclosure form so that all relevant
information can be given.
Note 6. In the case of an average price bargain, each underlying trade should
be disclosed.
For full details of disclosure requirements, see Rule 8 of the Code. If in
doubt, contact the Panel on Takeovers and Mergers, Monitoring Section, Tel. No:
020 7638 0129. E-mail:monitoring@disclosure.org.uk